PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
about
CIViC databaseAntagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancerThe promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1Gastric cancer - clinical and epidemiological aspects.Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutationsThe novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.Expression of PD-L1 and prognosis in breast cancer: a meta-analysis.Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.Genetic alteration profiling of patients with resected squamous cell lung carcinomas.Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability.Molecular Testing for Gastrointestinal Cancer.Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis.PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer.PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidenceNew agents on the horizon in gastric cancer.Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.Molecular classification of gastric cancer.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunologyPD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma.Prognostic significance of PD-L1 expression and 18F-FDG PET/CT in surgical pulmonary squamous cell carcinoma.Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer.EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release.PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study.Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.Porcine teschovirus 2 induces an incomplete autophagic response in PK-15 cells.Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4(+) T cells.Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab.
P2860
Q27612411-D11840EA-E5EB-4B13-9564-0478BB5CE4B9Q28066532-96A5FDDB-2115-4411-8289-5992CAABB46BQ28069924-B7617136-F961-4347-A9FE-61A440DB2257Q30248452-42226626-EA59-4431-B4AE-82712DF264AEQ33608197-1A416566-A51E-484E-938A-EF3A81970C2CQ33632116-FE6732A2-C840-42D0-B24E-80D12568128CQ33688662-0D887CED-E4F7-45D0-AD41-D377B2AB9C02Q36205148-0EED48F6-D091-4E45-8408-8A6E952D5BEDQ36353438-71CC488B-D322-4F8F-A88D-AEFD93437B02Q36358014-AD008C1C-8EDB-4EF9-A1D8-9AEFA11847CBQ37392781-7FA1910F-A054-42DE-A3EB-49BB93663409Q37706604-E7C76265-5423-4FED-B740-65ECB1F21877Q37710556-6B242D6E-036A-452A-8F89-D96F2300C1D4Q38369260-6964555F-BDC3-416B-88B2-AC05383629C3Q38630412-739B5084-BE95-4FA0-B8ED-9BA91CB50234Q38642012-E032266A-6725-4621-98A4-89EE66FBAD90Q38649562-FEC8ECF0-1C49-4E3B-890F-6C4A55F20694Q38759129-2F9D1DC2-4F0D-4FA1-AAB1-C8FC5B1AC6E8Q38896144-D5D2DFD9-D90D-4152-AA78-C2F4D95D37E1Q39038545-8BC2EFEA-F8B4-45B3-9894-B17D9B590539Q39101373-C0C90A3C-BB1C-4A9B-92DB-5B86D0D530A7Q41110505-1CDF5E54-D3C9-4676-9231-13399563A934Q41169821-C9E33A42-A705-411B-AFCA-758DDFD67208Q41550899-D2A2CC94-F30C-498A-9F6C-99416D12F3E2Q41612927-82F1A130-5BBA-462F-8458-1BD2FA20A143Q41708934-1123C98E-8677-4919-BC7E-8E140387C356Q41926342-A8B87419-AE56-4B42-B8FD-969BE73061AAQ42030787-09A24DB4-3490-40B8-80CA-ECE56EC12639Q42320529-AB0BFD32-E8CC-40FC-8074-93D32CD835ECQ43058997-2ADC974A-2608-4386-8201-FADE0A59A003Q45325453-4924A666-AFBA-4788-9831-17EBB57DC523Q45325629-1BA85B01-ED9D-4C2F-86E2-720C2B7E25FEQ47093886-71D8780B-8DE2-4487-BF1E-4852683857A0Q47137632-E346DC36-7533-4048-AC9E-11F4BDE3373DQ47143363-40B5230B-C566-4762-95A8-603D1E20C901Q47273046-3DF492D8-2BB9-4E53-89C6-675713D622FFQ47312352-C27D91A6-3292-43AB-A33F-357823AE6A58Q47728785-13B23BC4-B50A-4D72-89F6-9D8AA0A8D4FCQ48150040-C6D9D6A2-0E9E-4298-B543-983258A3C71FQ48274813-AB615354-FC11-4C31-9926-EE0DDA7669A7
P2860
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@ast
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@en
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@nl
type
label
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@ast
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@en
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@nl
altLabel
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
@en
prefLabel
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@ast
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@en
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@nl
P2093
P2860
P3181
P1433
P1476
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.
@en
P2093
Christine Böger
Hans-Michael Behrens
Holger Kalthoff
Micaela Mathiak
Sandra Krüger
P2860
P304
P3181
P356
10.18632/ONCOTARGET.18169
10.18632/ONCOTARGET.8169
P407
P577
2016-04-26T00:00:00Z